Stephen L. Mayo, Ph.D.

Stephen L. Mayo, Ph.D.

DirectoratMerck & Co.· In proxies 2023–2025

Stephen L. Mayo, Ph.D. sits on 3 public boards.

Boards1

  • Merck & Co.Director · 4 yr on the boardIndependentAudit, Research—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Merck & Co.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Allogene TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Sarepta TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?